
Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER
Description
About Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER
The Human Hemoglobin subunit alpha Peptide (IEDB: 144516) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hemoglobin Peptide, H-VGAHAGEYGAEALER-OH (Uniprot: P69905 aa: 18-32) from JPT is produced under strict quality control and quality management.
Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER - Specifications
- Peptide sequence: H-VGAHAGEYGAEALER-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Autoimmune disease
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER
References:
Read References with JPT’s Antigen Peptides
Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER has been described in:
Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands., J Immunol, 2008 (PMID: 18566446)
Peptides presented in vivo by HLA-DR in thyroid autoimmunity., Adv Immunol, 2008 (PMID: 19117535)
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19., PLoS Pathog, 2021 (PMID: 34529740)
Documentation
Documentation for Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER
Properties
Properties of Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Autoimmune disease |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Hemoglobin |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Hemoglobin subunit alpha 18-32, VGAHAGEYGAEALER
Information | Values |
---|---|
Sequence: | H-VGAHAGEYGAEALER-OH |
Specifications: | 15mer peptide as TFA salt |